Unknown

Dataset Information

0

Preparation and preliminary quality evaluation of aspirin/L-glutamate compound pellets.


ABSTRACT: L-glutamate is an important component of protein. It can prevent gastrointestinal damage caused by NSAIDs. We constructed two-phase enteric-coated granules of aspirin and L-glutamate compound by extrusion spheronization method and fluidized bed coating. The subliminal effective dose of L-glutamate is 100 mg/kg tested by model of gastric ulcer of rats induced by aspirin and drug administration. HPLC-UV and UV-Vis methods were adopted to determine content and cumulative release of aspirin and L-glutamate as quality analysis method indexes. The prescription and process optimization were carried out with yield, sphericity and dissolution. The two-phase compound granules have good sphericity of 0.93 ± 0.05 (aspirin pellets) and 0.94 ± 0.02 (L-glutamate pellets), content of salicylic acid (0.24 ± 0.03)%, dissolution of aspirin (2.36 ± 0.11)%. Quality evaluation and preliminary stability meet the commercial requirements. The stored environment of compound preparation should be sealed in a cool and dark place.

SUBMITTER: Xu M 

PROVIDER: S-EPMC8405465 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10180444 | biostudies-literature
| S-EPMC7455941 | biostudies-literature
2019-06-27 | GSE131398 | GEO
| S-EPMC6017071 | biostudies-literature
| S-EPMC6153682 | biostudies-literature
| S-EPMC10215955 | biostudies-literature
2019-06-27 | GSE131397 | GEO
2019-06-27 | GSE131396 | GEO
| S-EPMC2706224 | biostudies-literature
| S-EPMC5421875 | biostudies-literature